Veronica Chiang, MD, FAANS

• Abhijit Patel
• Adebowale Adeniran
• Alexandria Brackett
• Anna Arnal Estape
• Anne Chiang
• Annette Komlo
• Antonio Omuro
• Benjamin Y. Lu
• Cary Gross
• Charles Matouk
• Christopher J. Tien
• David J. Carlson
• David Schoenfeld
• Dijana Djureinovic
• Don Nguyen
• Francesc Lopez-Giraldez
• Harriet Kluger
• Heather Gerrish
• Henry S. Park
• James Bond
• James E. Hansen
• Jitendra Bhawnani
• Joseph King
• Joseph Piepmeier
• Juan Vasquez
• Judith Hess
• Jun Deng
• Katerina Politi
• Kelly Olino
• Kenneth B. Roberts
• Kimberly L. Johung
• Kurt Schalper
• Mariam Aboian
• Maxwell Laurans
• Michael DiLuna
• MingDe Lin
• Nadine Housri
• Nanthiya Sujijantarat
• Roy H. Decker
• Roy S. Herbst
• Ryan M Hebert
• Sacit Bulent Omay
• Sampada Chande
• Sanjay Aneja
• Sarah Goldberg
• Sarah Weiss
• Scott Gettinger
• Stephanie Robert
• Thuy Tran
• Yi An
• Zhe Jay Chen

Brain Neoplasms; Neoplasm Metastasis; Neurosurgery; Radiation Effects; Radiosurgery; Radiation Oncology

• Lenvatinib or anti-VEGF in combination with anti-PD-1 differentially augments anti-tumor activity in melanomaTran T, Caulfield J, Zhang L, Schoenfeld D, Djureinovic D, Chiang V, Oria V, Weiss S, Olino K, Jilaveanu L, Kluger H. Lenvatinib or anti-VEGF in combination with anti-PD-1 differentially augments anti-tumor activity in melanoma. JCI Insight 2023, 8: e157347. PMID: 36821392, PMCID: PMC10132152, DOI: 10.1172/jci.insight.157347.
• Use of stereotactic radiosurgery in treatment of brain metastases from pediatric extracranial solid tumorsXu S, Campbell A, Chiang V, Bindra R, Vasquez J, Pashankar F. Use of stereotactic radiosurgery in treatment of brain metastases from pediatric extracranial solid tumors. Pediatric Blood & Cancer 2023, 70: e30303. PMID: 36975152, DOI: 10.1002/pbc.30303.
• Efficacy of laser interstitial thermal therapy for biopsy-proven radiation necrosis in radiographically recurrent brain metastasesChan M, Tatter S, Chiang V, Fecci P, Strowd R, Prabhu S, Hadjipanayis C, Kirkpatrick J, Sun D, Sinicrope K, Mohammadi A, Sevak P, Abram S, Kim A, Leuthardt E, Chao S, Phillips J, Lacroix M, Williams B, Placantonakis D, Silverman J, Baumgartner J, Piccioni D, Laxton A. Efficacy of laser interstitial thermal therapy for biopsy-proven radiation necrosis in radiographically recurrent brain metastases. Neuro-Oncology Advances 2023, 5: vdad031. PMID: 37114245, PMCID: PMC10129388, DOI: 10.1093/noajnl/vdad031.
• Management of patients with brain metastases from NSCLC without a genetic driver alteration: upfront radiotherapy or immunotherapy?Merkin R, Chiang V, Goldberg S. Management of patients with brain metastases from NSCLC without a genetic driver alteration: upfront radiotherapy or immunotherapy? Therapeutic Advances In Medical Oncology 2023, 15: 17588359231175438. PMID: 37275964, PMCID: PMC10233588, DOI: 10.1177/17588359231175438.
• Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancerAdua S, Arnal-Estapé A, Zhao M, Qi B, Liu Z, Kravitz C, Hulme H, Strittmatter N, López-Giráldez F, Chande S, Albert A, Melnick M, Hu B, Politi K, Chiang V, Colclough N, Goodwin R, Cross D, Smith P, Nguyen D. Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer. Nature Communications 2022, 13: 7690. PMID: 36509758, PMCID: PMC9744876, DOI: 10.1038/s41467-022-34889-z.
• Stereotactic radiosurgery and local control of brain metastases from triple-negative breast cancer.Kowalchuk R, Niranjan A, Hess J, Antonios J, Zhang M, Braunstein S, Ross R, Pikis S, Deibert C, Lee C, Yang H, Langlois A, Mathieu D, Peker S, Samanci Y, Rusthoven C, Chiang V, Wei Z, Lunsford L, Trifiletti D, Sheehan J. Stereotactic radiosurgery and local control of brain metastases from triple-negative breast cancer. Journal Of Neurosurgery 2022, 1-7. PMID: 36433878, DOI: 10.3171/2022.10.jns221900.
• NIMG-02. PACS-INTEGRATED AUTO-SEGMENTATION WORKFLOW FOR BRAIN METASTASES USING NNU-NETJekel L, Bousabarah K, Lin M, Merkaj S, Kaur M, Avesta A, Aneja S, Omuro A, Chiang V, Scheffler B, Aboian M. NIMG-02. PACS-INTEGRATED AUTO-SEGMENTATION WORKFLOW FOR BRAIN METASTASES USING NNU-NET. Neuro-Oncology 2022, 24: vii162-vii162. PMCID: PMC9661012, DOI: 10.1093/neuonc/noac209.622.
• NIMG-07. APPLYING A GLIOMA-TRAINED DEEP LEARNING AUTO-SEGMENTATION TOOL ON BM PRE- AND POST-RADIOSURGERYKaur M, Varghese S, Jekel L, Tillmanns N, Merkaj S, Bousabarah K, Lin M, Bhawnani J, Chiang V, Aboian M. NIMG-07. APPLYING A GLIOMA-TRAINED DEEP LEARNING AUTO-SEGMENTATION TOOL ON BM PRE- AND POST-RADIOSURGERY. Neuro-Oncology 2022, 24: vii162-vii163. PMCID: PMC9660643, DOI: 10.1093/neuonc/noac209.626.
• NIMG-04. LONGITUDINAL TRACKING OF PERITUMORAL EDEMA VOLUME USING PACS-INTEGRATED TOOLS PROVIDES CRITICAL INFORMATION IN TREATMENT ASSESSMENT OF NSCLC BRAIN METASTASES AFTER RADIOSURGERYKaur M, Petersen G, von Reppert M, Jekel L, de Santo I, Varghese S, Chiang V, Aboian M. NIMG-04. LONGITUDINAL TRACKING OF PERITUMORAL EDEMA VOLUME USING PACS-INTEGRATED TOOLS PROVIDES CRITICAL INFORMATION IN TREATMENT ASSESSMENT OF NSCLC BRAIN METASTASES AFTER RADIOSURGERY. Neuro-Oncology 2022, 24: vii162-vii162. PMCID: PMC9661156, DOI: 10.1093/neuonc/noac209.624.
• SURG-23. EFFICACY OF LASER INTERSTITIAL THERMAL THERAPY (LITT) FOR NEWLY DIAGNOSED AND RECURRENT IDH WILD-TYPE GLIOBLASTOMAde Groot J, Kim A, Prabhu S, Rao G, Laxton A, Fecci P, O'Brien B, Sloan A, Chiang V, Tatter S, Mohammadi A, Placantonakis D, Strowd R, Chen C, Hadjipanayis C, Khasraw M, Sun D, Piccioni D, Sinicrope K, Campian J, Kurz S, Williams B, Smith K, Tovar-Spinoza Z, Leuthardt E. SURG-23. EFFICACY OF LASER INTERSTITIAL THERMAL THERAPY (LITT) FOR NEWLY DIAGNOSED AND RECURRENT IDH WILD-TYPE GLIOBLASTOMA. Neuro-Oncology 2022, 24: vii256-vii257. PMCID: PMC9660753, DOI: 10.1093/neuonc/noac209.989.
• 513 Surveilling Cerebrospinal Fluid Protein Biomarkers in Brain MetastasisCheok S, Arnal-Estape A, Wei W, Nguyen D, Chiang V. 513 Surveilling Cerebrospinal Fluid Protein Biomarkers in Brain Metastasis. Neurosurgery 2022, 68: 129-129. DOI: 10.1227/neu.0000000000001880_513.
• Role of Gamma Knife Radiosurgery in Small Cell Lung Cancer: A Multi-Institutional Retrospective Study of the International Radiosurgery Research Foundation (IRRF)Cifarelli C, Vargo J, Fang W, Liscak R, Guseynova K, Warnick R, Lee C, Yang H, Borghei-Razavi H, Maiti T, Siddiqui Z, Yuan J, Grills I, Mathieu D, Touchette C, Cordeiro D, Chiang V, Hess J, Tien C, Faramand A, Kano H, Barnett G, Sheehan J, Lunsford L. Role of Gamma Knife Radiosurgery in Small Cell Lung Cancer: A Multi-Institutional Retrospective Study of the International Radiosurgery Research Foundation (IRRF). Neurosurgery 2021, 89: s20-s20. DOI: 10.1093/neuros/nyz428_s020.
• Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN): 12-Month Outcomes and Quality of Life After Brain Tumor AblationKim A, Tatter S, Rao G, Prabhu S, Chen C, Fecci P, Chiang V, Smith K, Williams B, Mohammadi A, Judy K, Sloan A, Tovar-Spinoza Z, Baumgartner J, Hadjipanayis C, Leuthardt E. Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN): 12-Month Outcomes and Quality of Life After Brain Tumor Ablation. Neurosurgery 2021, 89: s16-s16. PMCID: PMC8600280, DOI: 10.1093/neuros/nyaa071_s016.
• Recognition and Management of Adverse Radiation EffectsCheok S, Hansen J, Chiang V. Recognition and Management of Adverse Radiation Effects. 2021, 391-404. DOI: 10.1201/9781003167464-36.
• Management of Brain MetastasesCollier E, Chiang V, Goldberg S. Management of Brain Metastases. 2021, 115-137. DOI: 10.1007/978-3-030-74028-3_6.
• SURG-02. Stereotactic Laser Ablation (SLA) followed by consolidation stereotactic radiosurgery (SRS) as a treatment strategy for brain metastasis that recurred locally after initial radiosurgery (BMRS): a collaborative institutional experiencePena-Pino I, Ma J, Hori Y, Fomchenko E, Dusenbery K, Reynolds M, Wilke C, Yuan J, Barnett G, Chiang V, Mohammadi A, Chen C. SURG-02. Stereotactic Laser Ablation (SLA) followed by consolidation stereotactic radiosurgery (SRS) as a treatment strategy for brain metastasis that recurred locally after initial radiosurgery (BMRS): a collaborative institutional experience. Neuro-Oncology Advances 2021, 3: iii23-iii23. PMCID: PMC8351296, DOI: 10.1093/noajnl/vdab071.095.
• NIMG-03. DEEP LEARNING SURVIVAL ANALYSIS FOR MULTIPLE BRAIN METASTASESChang E, Joel M, Chang H, Du J, Yu J, An Y, Hansen J, Omuro A, Chiang V, Aneja S. NIMG-03. DEEP LEARNING SURVIVAL ANALYSIS FOR MULTIPLE BRAIN METASTASES. Neuro-Oncology 2020, 22: ii147-ii147. PMCID: PMC7650895, DOI: 10.1093/neuonc/noaa215.616.
• Stereotactic Radiosurgery for Pediatric Arteriovenous Malformations: A Case Series Reflecting One Institution’s Experience With TreatmentChoi R, An Y, Aneja S, Bindra R, Bond J, Chiang V, Hansen J, Hebert R, Matouk C, Yu J. Stereotactic Radiosurgery for Pediatric Arteriovenous Malformations: A Case Series Reflecting One Institution’s Experience With Treatment. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e244. DOI: 10.1016/j.ijrobp.2020.07.589.
• Deep Learning Survival Analysis for Brain Metastases Treated with Stereotactic RadiosurgeryChang E, Joel M, Chang H, Du J, Yu J, An Y, Hansen J, Omuro A, Chiang V, Aneja S. Deep Learning Survival Analysis for Brain Metastases Treated with Stereotactic Radiosurgery. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: s164-s165. DOI: 10.1016/j.ijrobp.2020.07.932.
• Outcomes Of Stereotactic Radiosurgery And Immunotherapy In Renal Cell Carcinoma With Brain MetastasesUezono H, Nam D, Yu J, Chiang V. Outcomes Of Stereotactic Radiosurgery And Immunotherapy In Renal Cell Carcinoma With Brain Metastases. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e734. DOI: 10.1016/j.ijrobp.2020.07.133.
• Report from the American Radium Society (ARS) Appropriate Use Criteria Brain Malignancies Panel: Treatment of Multiple Brain MetastasesMilano M, Chiang V, Soltys S, Wang T, Lo S, Brackett A, Gephart M, Nagpal S, Jabbari S, Halasz L, Chao S, Garg A, Knisely J, Sahgal A, Chang E. Report from the American Radium Society (ARS) Appropriate Use Criteria Brain Malignancies Panel: Treatment of Multiple Brain Metastases. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e27-e28. DOI: 10.1016/j.ijrobp.2020.02.527.
• 35. EVALUATING CSF CIRCULATING TUMOR DNA IN INTRAPARENCHYMAL BRAIN METASTASISCheok S, Narayan A, Arnal-Estape A, Patel A, Nguyen D, Chiang V. 35. EVALUATING CSF CIRCULATING TUMOR DNA IN INTRAPARENCHYMAL BRAIN METASTASIS. Neuro-Oncology Advances 2020, 2: ii6-ii6. PMCID: PMC7401400, DOI: 10.1093/noajnl/vdaa073.023.
• LITT for Metastatic In-Field RecurrenceSujijantarat N, Danish S, Chiang V. LITT for Metastatic In-Field Recurrence. 2020, 51-64. DOI: 10.1007/978-3-030-48047-9_5.
• Technical Considerations for LITT: Getting Through the ProcedurePatel N, Hanft S, Chiang V, Gonda D, Neimat J, Danish S. Technical Considerations for LITT: Getting Through the Procedure. 2020, 19-36. DOI: 10.1007/978-3-030-48047-9_2.
• Radiation Necrosis Following the Radiosurgical Treatment of Brain MetastasesRobert S, Chiang V. Radiation Necrosis Following the Radiosurgical Treatment of Brain Metastases. 2020, 393-405. DOI: 10.1007/978-3-030-42958-4_28.
• RBTT-07. A PHASE 2 TRIAL OF PEMBROLIZUMAB AND BEVACIZUMAB IN MELANOMA BRAIN MET PATIENTSKluger H, Forsyth P, Khushalani N, Eroglu Z, Sznol M, Tran T, Jilaveanu L, Cohen J, Hegde U, Wei W, Mahajan A, Goldberg S, Chiang V, Weiss S. RBTT-07. A PHASE 2 TRIAL OF PEMBROLIZUMAB AND BEVACIZUMAB IN MELANOMA BRAIN MET PATIENTS. Neuro-Oncology 2019, 21: vi220-vi220. PMCID: PMC6847787, DOI: 10.1093/neuonc/noz175.919.
• Combining Radiosurgery and Systemic Therapies for Treatment of Brain MetastasesChiang V, Cheok S. Combining Radiosurgery and Systemic Therapies for Treatment of Brain Metastases. 2019, 247-258. DOI: 10.1007/978-3-030-23417-1_19.
• Upfront Stereotactic Radiosurgery in the Treatment of Brain Metastasis from Small Cell Lung CancerMiccio J, Johnson S, Jairam V, Yu J, Hansen J, Aneja S, An Y, Decker R, Omay S, Chiang V, Park H. Upfront Stereotactic Radiosurgery in the Treatment of Brain Metastasis from Small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: e81-e82. DOI: 10.1016/j.ijrobp.2019.06.2348.
• Impact of Tissue Heterogeneity Correction on Stereotactic Radiosurgery of Acoustic NeuromasWelch G, Tien C, Chiang V, Yu J, Hansen J, Aneja S. Impact of Tissue Heterogeneity Correction on Stereotactic Radiosurgery of Acoustic Neuromas. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: e785. DOI: 10.1016/j.ijrobp.2019.06.749.
• Cerebrospinal Fluid Biomarkers of Brain MetastasisCheok S, Arnal-Estape A, Narayan A, Zakaria M, Goldberg S, Patel A, Nguyen D, Chiang V. Cerebrospinal Fluid Biomarkers of Brain Metastasis. Neurosurgery 2019, 66: 310-631. DOI: 10.1093/neuros/nyz310_631.
• MLTI-06. BEVACIZUMAB VERSUS SURGICAL INTERVENTION FOR RADIATION NECROSIS IN PREVIOUSLY IRRADIATED BRAIN METASTASESHong C, Sujijantarat N, Chiang V. MLTI-06. BEVACIZUMAB VERSUS SURGICAL INTERVENTION FOR RADIATION NECROSIS IN PREVIOUSLY IRRADIATED BRAIN METASTASES. Neuro-Oncology Advances 2019, 1: i15-i15. PMCID: PMC7213266, DOI: 10.1093/noajnl/vdz014.065.
• SURG-06. LASER INTERSTITIAL THERMAL THERAPY COMPARED TO CRANIOTOMY FOR TREATMENT OF RADIATION NECROSIS OR RECURRENT TUMOR IN BRAIN METASTASES FAILING RADIOSURGERYHong C, Deng D, Sujijantarat N, Vera A, Chiang V. SURG-06. LASER INTERSTITIAL THERMAL THERAPY COMPARED TO CRANIOTOMY FOR TREATMENT OF RADIATION NECROSIS OR RECURRENT TUMOR IN BRAIN METASTASES FAILING RADIOSURGERY. Neuro-Oncology Advances 2019, 1: i31-i32. PMCID: PMC7213364, DOI: 10.1093/noajnl/vdz014.141.
• RADI-31. MULTI-INSTITUTIONAL VALIDATION OF BRAIN METASTASIS VELOCITY, A RECENTLY DEFINED PREDICTOR OF OUTCOMES FOLLOWING STEREOTACTIC RADIOSURGERYChan M, McTyre E, Soike M, Ayala-Peacock D, Hepel J, Page B, Contessa J, Chiang V, Attia A, Braunstein S, Chung C, Ruiz J, Fiveash J, Chao S, Farris M. RADI-31. MULTI-INSTITUTIONAL VALIDATION OF BRAIN METASTASIS VELOCITY, A RECENTLY DEFINED PREDICTOR OF OUTCOMES FOLLOWING STEREOTACTIC RADIOSURGERY. Neuro-Oncology Advances 2019, 1: i28-i28. PMCID: PMC7213264, DOI: 10.1093/noajnl/vdz014.123.
• Postoperative Management in the Neurocritical Care UnitGrant R, Redmond A, Chiang V. Postoperative Management in the Neurocritical Care Unit. 2019, 299-313. DOI: 10.1017/9781107587908.024.
• Abstract 4552: BMX-Seq as a new resource for deciphering the transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasisWingrove E, Liu Z, Nguyen D, Arnal-Estape A, Patel K, Melnick M, Politi K, Valiente M, Kluger H, Chiang V. Abstract 4552: BMX-Seq as a new resource for deciphering the transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis. 2019, 4552-4552. DOI: 10.1158/1538-7445.sabcs18-4552.
• Abstract 4552: BMX-Seq as a new resource for deciphering the transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasisWingrove E, Liu Z, Nguyen D, Arnal-Estape A, Patel K, Melnick M, Politi K, Valiente M, Kluger H, Chiang V. Abstract 4552: BMX-Seq as a new resource for deciphering the transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis. Cancer Research 2019, 79: 4552-4552. DOI: 10.1158/1538-7445.am2019-4552.
• Transcriptomic Hallmarks of Tumor Plasticity and Stromal Interactions in Brain MetastasisWingrove E, Liu Z, Patel K, Arnal‐Estape A, Melnick M, Politi K, Monteiro C, Zhu L, Valiente M, Kluger H, Chiang V, Nguyen D. Transcriptomic Hallmarks of Tumor Plasticity and Stromal Interactions in Brain Metastasis. The FASEB Journal 2019, 33: 368.8-368.8. DOI: 10.1096/fasebj.2019.33.1_supplement.368.8.
• Results of a pilot/phase II study of gamma knife radiosurgery for brain metastases and implications for future prospective clinical trialsYu J, Singh C, Bindra R, Contessa J, Husain Z, Hansen J, Park H, Roberts K, Bond J, Tien C, Guo F, Colaco R, Housri N, Magnuson W, Mahajan A, Omay S, Chiang V. Results of a pilot/phase II study of gamma knife radiosurgery for brain metastases and implications for future prospective clinical trials. Journal Of Radiation Oncology 2019, 8: 39-46. DOI: 10.1007/s13566-018-0370-7.
• SURG-03. A COMPARISON OF SURVIVAL OUTCOMES AFTER BIOPSY VERSUS RESECTION IN PRIMARY CNS LYMPHOMA: A SINGLE INSTITUTION EXPERIENCEHong C, Barbiero F, Chiang V, Moliterno J, Piepmeier J, Corbin Z, Baehring J. SURG-03. A COMPARISON OF SURVIVAL OUTCOMES AFTER BIOPSY VERSUS RESECTION IN PRIMARY CNS LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE. Neuro-Oncology 2018, 20: vi250-vi250. PMCID: PMC6216251, DOI: 10.1093/neuonc/noy148.1039.
• SURG-15. UPFRONT MRI-GUIDED STEREOTACTIC LASER-ABLATION IN NEWLY DIAGNOSED GLIOBLASTOMA: A MULTICENTER REVIEW OF SURVIVAL OUTCOMES COMPARED TO A MATCHED COHORT OF BIOPSY-ONLY PATIENTSMohammadi A, Sharma M, Beaumont T, Juarez K, Kemeny H, Dechant C, Seas A, Sarmey N, Lee B, Jia X, Fecci P, Baehring J, Moliterno J, Chiang V, Ahluwalia M, Kim A, Barnett G, Leuthardt E. SURG-15. UPFRONT MRI-GUIDED STEREOTACTIC LASER-ABLATION IN NEWLY DIAGNOSED GLIOBLASTOMA: A MULTICENTER REVIEW OF SURVIVAL OUTCOMES COMPARED TO A MATCHED COHORT OF BIOPSY-ONLY PATIENTS. Neuro-Oncology 2018, 20: vi253-vi254. PMCID: PMC6216291, DOI: 10.1093/neuonc/noy148.1051.
• SURG-06. LASER ABLATION FOR BRAIN METASTASES: SAFETY AND PRELIMINARY OUTCOMES FROM THE LASER ABLATION OF ABNORMAL NEUROLOGICAL TISSUE USING ROBOTIC NEUROBLATE SYSTEM (LAANTERN) REGISTRYKamath A, Tatter S, Fecci P, Chen C, Chiang V, Rao G, Mohammadi A, Judy K, Field M, Neimat J, Leuthardt E, Kim A. SURG-06. LASER ABLATION FOR BRAIN METASTASES: SAFETY AND PRELIMINARY OUTCOMES FROM THE LASER ABLATION OF ABNORMAL NEUROLOGICAL TISSUE USING ROBOTIC NEUROBLATE SYSTEM (LAANTERN) REGISTRY. Neuro-Oncology 2018, 20: vi251-vi251. PMCID: PMC6216263, DOI: 10.1093/neuonc/noy148.1042.
• SURG-20. LASER-INTERSTITIAL THERMAL THERAPY VERSUS CRANIOTOMY FOR TREATMENT OF RADIATION NECROSIS OR RECURRENT TUMOR IN BRAIN METASTASES FAILING RADIOSURGERYHong C, Deng J, Vera A, Chiang V. SURG-20. LASER-INTERSTITIAL THERMAL THERAPY VERSUS CRANIOTOMY FOR TREATMENT OF RADIATION NECROSIS OR RECURRENT TUMOR IN BRAIN METASTASES FAILING RADIOSURGERY. Neuro-Oncology 2018, 20: vi254-vi255. PMCID: PMC6216306, DOI: 10.1093/neuonc/noy148.1056.
• Evolving National Practice Patterns of Hypofractionated Stereotactic Radiation Therapy Versus Single-Fraction Radiosurgery for Brain MetastasesJairam V, Kann B, Patel K, Yu J, Hansen J, Husain Z, Bindra R, Contessa J, Omay S, Chiang V, Park H. Evolving National Practice Patterns of Hypofractionated Stereotactic Radiation Therapy Versus Single-Fraction Radiosurgery for Brain Metastases. International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e227. DOI: 10.1016/j.ijrobp.2018.07.775.
• A Pilot/Phase II Study of Stereotactic Radiosurgery for Brain Metastases Using Rational Dose SelectionYu J, Singh C, Bindra R, Contessa J, Husain Z, Hansen J, Park H, Roberts K, Bond J, Tien C, Guo F, Colaco R, Housri N, Magnuson W, Omay B, Chiang V. A Pilot/Phase II Study of Stereotactic Radiosurgery for Brain Metastases Using Rational Dose Selection. International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e372-e373. DOI: 10.1016/j.ijrobp.2018.07.1113.
• Salvage Stereotactic Radiosurgery is Associated with Improved Overall Survival Compared to Whole Brain Radiation in the Setting of Progressive Brain MetastasesSoike M, McTyre E, Farris M, Ayala-Peacock D, Hepel J, Page B, Kleinberg L, Contessa J, Chiang V, Cramer C, Ruiz J, Pasche B, Tatter S, Fiveash J, Ahluwalia M, Chao S, Braunstein S, Attia A, Chan M. Salvage Stereotactic Radiosurgery is Associated with Improved Overall Survival Compared to Whole Brain Radiation in the Setting of Progressive Brain Metastases. International Journal Of Radiation Oncology • Biology • Physics 2018, 102: s144. DOI: 10.1016/j.ijrobp.2018.06.350.
• Initial SRS for Patients with 5-15 Brain Metastases: Results of a Multi-Institutional ExperienceHughes R, Masters A, McTyre E, Farris M, Chung C, Page B, Kleinberg L, Hepel J, Contessa J, Chiang V, Ruiz J, Watabe K, Su J, Fiveash J, Braunstein S, Chao S, Attia A, Ayala-Peacock D, Chan M. Initial SRS for Patients with 5-15 Brain Metastases: Results of a Multi-Institutional Experience. International Journal Of Radiation Oncology • Biology • Physics 2018, 102: s141-s142. DOI: 10.1016/j.ijrobp.2018.06.346.
• 304 Safety of Laser Ablation for Brain TumorsKamath A, Kim A, Chen C, Tatter S, Fecci P, Toyota B, Chiang V, Mohammadi A, Rao G, Judy K, Field M, Sloan A, Neimat J, Leuthardt E. 304 Safety of Laser Ablation for Brain Tumors. Neurosurgery 2018, 65: 123-124. DOI: 10.1093/neuros/nyy303.304.
• Durability of brain metastasis response and overall survival in patients with non-small cell lung cancer (NSCLC) treated with pembrolizumab.Goldberg S, Gettinger S, Mahajan A, Herbst R, Chiang A, Lilenbaum R, Jilaveanu L, Rowen E, Gerrish H, Komlo A, Wei W, Chiang V, Kluger H. Durability of brain metastasis response and overall survival in patients with non-small cell lung cancer (NSCLC) treated with pembrolizumab. Journal Of Clinical Oncology 2018, 36: 2009-2009. DOI: 10.1200/jco.2018.36.15_suppl.2009.
• Perilesional edema and blood vessel characteristics in brain metastases and implications for treatment with immune therapy.Tran T, Jilaveanu L, Mahajan A, Goldberg S, Nguyen D, Chiang V, Kluger H. Perilesional edema and blood vessel characteristics in brain metastases and implications for treatment with immune therapy. Journal Of Clinical Oncology 2018, 36: 9572-9572. DOI: 10.1200/jco.2018.36.15_suppl.9572.
• PD-L1 expression and tumor-infiltrating lymphocytes in lung cancer brain metastases.Lu B, Gupta R, Ribeiro M, Stewart T, Chiang V, Contessa J, Adeniran A, Kluger H, Jilaveanu L, Schalper K, Goldberg S. PD-L1 expression and tumor-infiltrating lymphocytes in lung cancer brain metastases. Journal Of Clinical Oncology 2018, 36: e24116-e24116. DOI: 10.1200/jco.2018.36.15_suppl.e24116.
• SURG-06. LASER ABLATION IN STEREOTACTIC NEUROSURGERY (LAISE): A MULTI-INSTITUTIONAL RETROSPECTIVE ANALYSIS OF LITT FOR BRAIN METASTASISSloan A, Tatter S, Mohammadi A, Judy K, Prabhu S, Lovick D, Chamoun R, Chiang V, Leuthardt E. SURG-06. LASER ABLATION IN STEREOTACTIC NEUROSURGERY (LAISE): A MULTI-INSTITUTIONAL RETROSPECTIVE ANALYSIS OF LITT FOR BRAIN METASTASIS. Neuro-Oncology 2017, 19: vi236-vi236. PMCID: PMC5693010, DOI: 10.1093/neuonc/nox168.963.
• SURG-21. LASER ABLATION IN STEREOTACTIC NEUROSURGERY (LAISE): A MULTI-INSTITUTIONAL RETROSPECTIVE ANALYSIS OF LITT FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMAS (GBMS)Sloan A, Tatter S, Mohammadi A, Judy K, Prabhu S, Lovick D, Chamoun R, Chiang V, Leuthardt E. SURG-21. LASER ABLATION IN STEREOTACTIC NEUROSURGERY (LAISE): A MULTI-INSTITUTIONAL RETROSPECTIVE ANALYSIS OF LITT FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMAS (GBMS). Neuro-Oncology 2017, 19: vi239-vi240. PMCID: PMC5693007, DOI: 10.1093/neuonc/nox168.977.
• Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter studyKaidar-Person O, Meattini I, Jain P, Bult P, Simone N, Kindts I, Steffens R, Weltens C, Navarria P, Belkacemi Y, Lopez-Guerra J, Livi L, Baumert B, Vieites B, Limon D, Kurman N, Ko K, Yu J, Chiang V, Poortmans P, Zagar T. Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter study. Breast Cancer Research And Treatment 2017, 167: 479-483. PMID: 28975433, DOI: 10.1007/s10549-017-4526-8.
• Stereotactic Radiosurgery for Trigeminal Neuralgia in Patients with Multiple Sclerosis: A Multicenter StudyXu Z, Mathieu D, Heroux F, Abbassy M, Barnett G, Mohammadi A, Kano H, Caruso J, Grills I, Lee K, Krishnan S, Kaufmann A, Lee J, Pierce J, Maloney E, Kondziolka D, Hess J, Chiang V, Lunsford L, Sheehan J. Stereotactic Radiosurgery for Trigeminal Neuralgia in Patients with Multiple Sclerosis: A Multicenter Study. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: s186-s187. DOI: 10.1016/j.ijrobp.2017.06.465.
• Radiosurgery for Brain Metastases: Practice Patterns and Disparities in the United StatesKann B, Park H, Chiang V, Yu J. Radiosurgery for Brain Metastases: Practice Patterns and Disparities in the United States. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e83-e84. DOI: 10.1016/j.ijrobp.2017.06.790.
• Prognostic Factors in Patients with Renal Cell Carcinoma and Brain MetastasesSperduto P, Deegan B, Li J, Jethwa K, Brown P, Lockney N, Beal K, Rana N, Attia A, Shanley R, Lou E, Zahra A, Buatti J, Molitoris J, Yu J, Chiang V, Masucci G, Roberge D, Olson A, Kirkpatrick J, Braunstein S, Sneed P, Shi D, Shih H, Mehta M. Prognostic Factors in Patients with Renal Cell Carcinoma and Brain Metastases. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: s169-s170. DOI: 10.1016/j.ijrobp.2017.06.429.
• Discrepancies Between Biological Markers of Primary Breast Cancer and Their Brain Metastases: An International Multicenter StudyPerson O, Meattini I, Jain P, Bult P, Simone N, Kindts I, Steffens R, Weltens C, Navarria P, Belkacemi Y, Lopez J, Livi L, Baumert B, Vieites B, Limon D, Kurman N, Yu J, Chiang V, Poortmans P, Zagar T. Discrepancies Between Biological Markers of Primary Breast Cancer and Their Brain Metastases: An International Multicenter Study. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: s170-s171. DOI: 10.1016/j.ijrobp.2017.06.431.
• (S030) Early SRS of Melanoma Brain Metastases in Patients Treated With IpilimumabAn Y, Jiang W, Chiang V, Li J. (S030) Early SRS of Melanoma Brain Metastases in Patients Treated With Ipilimumab. International Journal Of Radiation Oncology • Biology • Physics 2017, 98: e9. DOI: 10.1016/j.ijrobp.2017.02.066.
• Management of Melanoma Brain MetastasesQian J, Chiang V. Management of Melanoma Brain Metastases. 2017 DOI: 10.1891/9781617052958.0011.
• The Role of Laser-Induced Thermal Therapy in the Management of Malignant GliomasFomchenko E, Chiang V. The Role of Laser-Induced Thermal Therapy in the Management of Malignant Gliomas. 2016, 103-119. DOI: 10.1007/978-3-319-49864-5_7.
• BMET-24. LASER ABLATION AFTER STEREOTACTIC RADIOSURGERY (LAASR) – RESULTS OF A MULTI-CENTERED PROSPECTIVE STUDYChiang V, Dietrich J, Tatter S, Mohammadi A, Leuthardt E, Chamoun R, Judy K, Barnett G, Ahluwalia M. BMET-24. LASER ABLATION AFTER STEREOTACTIC RADIOSURGERY (LAASR) – RESULTS OF A MULTI-CENTERED PROSPECTIVE STUDY. Neuro-Oncology 2016, 18: vi31-vi31. DOI: 10.1093/neuonc/now212.124.
• Deferring Radiation Therapy for Brain Metastases in Patients With EGFR-Mutant Non-Small Cell Lung Cancer: A Multi-Institutional AnalysisMagnuson W, Amini A, Patil T, Kavanagh B, Camidge D, Braunstein S, Boreta L, Attia A, Rana N, Contessa J, Gettinger S, Lester-Coll N, Yu J, Chiang V. Deferring Radiation Therapy for Brain Metastases in Patients With EGFR-Mutant Non-Small Cell Lung Cancer: A Multi-Institutional Analysis. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s57-s58. DOI: 10.1016/j.ijrobp.2016.06.149.
• The Impact of Cobalt-60 Source Age on Biologically Effective Dose in Stereotactic Radiosurgery ThalamotomyKann B, Yu J, Bond J, Loiselle C, Chiang V, Bindra R, Gerrard J, Carlson D. The Impact of Cobalt-60 Source Age on Biologically Effective Dose in Stereotactic Radiosurgery Thalamotomy. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e563. DOI: 10.1016/j.ijrobp.2016.06.2038.
• The Effect of Gene Mutations on Survival in Patients With Melanoma Following the Development of Brain MetastasesSperduto P, Jiang W, Brown P, Braunstein S, Sneed P, Wattson D, Shih H, Bangdiwala A, Shanley R, Lockney N, Beal K, Lou E, Amatruda T, Sperduto W, Kirkpatrick J, Yeh N, Gaspar L, Molitoris J, Masucci L, Roberge D, Yu J, Chiang V, Mehta M. The Effect of Gene Mutations on Survival in Patients With Melanoma Following the Development of Brain Metastases. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s178. DOI: 10.1016/j.ijrobp.2016.06.447.
• Ceritinib enables stereotactic radiosurgery to a previously untreatable symptomatic brain metastasis in a patient with ALK rearranged non-small cell lung cancerQian J, Yu J, Gettinger S, Chiang V. Ceritinib enables stereotactic radiosurgery to a previously untreatable symptomatic brain metastasis in a patient with ALK rearranged non-small cell lung cancer. Cancer Treatment And Research Communications 2016, 6: 17-19. DOI: 10.1016/j.ctrc.2016.02.002.
• SURG-20A MULTICENTER SURVIVAL ANALYSIS OF UPFRONT LASER-ABLATION FOR TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMAMohammadi A, Chiang V, Beaumont T, Elson P, Barnett G, Leuthardt E. SURG-20A MULTICENTER SURVIVAL ANALYSIS OF UPFRONT LASER-ABLATION FOR TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. Neuro-Oncology 2015, 17: v218-v218. PMCID: PMC4639277, DOI: 10.1093/neuonc/nov235.20.
• Spine Stereotactic Body Radiation Therapy Outcomes in Patients With Concurrent Brain MetastasesPark H, Colaco R, Laurans M, Chiang V, Yu J, Husain Z. Spine Stereotactic Body Radiation Therapy Outcomes in Patients With Concurrent Brain Metastases. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e62. DOI: 10.1016/j.ijrobp.2015.07.702.
• Prognostic Factors for Seizures After First Radiosurgical Treatment in Patients With Brain MetastasesJairam V, Chiang V, Yu J. Prognostic Factors for Seizures After First Radiosurgical Treatment in Patients With Brain Metastases. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e100. DOI: 10.1016/j.ijrobp.2015.07.802.
• Shifts in Stereotactic Radiosurgery Platform Utilization for Brain Metastases in the United StatesPark H, Wang E, Rutter C, Corso C, Chiang V, Yu J. Shifts in Stereotactic Radiosurgery Platform Utilization for Brain Metastases in the United States. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e62. DOI: 10.1016/j.ijrobp.2015.07.701.
• Activity and safety of pembrolizumab in patients with metastatic non-small cell lung cancer with untreated brain metastases.Goldberg S, Gettinger S, Mahajan A, Herbst R, Chiang A, Tsiouris A, Vortmeyer A, Jilaveanu L, Speaker S, Madura M, Rowen E, Gerrish H, Knapp-Perry E, Yao X, Chiang V, Kluger H. Activity and safety of pembrolizumab in patients with metastatic non-small cell lung cancer with untreated brain metastases. Journal Of Clinical Oncology 2015, 33: 8035-8035. DOI: 10.1200/jco.2015.33.15_suppl.8035.
• Safety and activity of pembrolizumab in melanoma patients with untreated brain metastases.Kluger H, Goldberg S, Sznol M, Tsiouris J, Vortmeyer A, Jilaveanu L, Ralabate A, Rivera A, Burke M, Hegbe U, Cohen J, Yao X, Speaker S, Madura M, Knapp-Perry E, Mahajan A, Chiang V. Safety and activity of pembrolizumab in melanoma patients with untreated brain metastases. Journal Of Clinical Oncology 2015, 33: 9009-9009. DOI: 10.1200/jco.2015.33.15_suppl.9009.
• BM-10SYSTEMIC TREATMENT AND RADIATION NECROSIS FOLLOWING GKSRS IN THE TREATMENT OF BRAIN METASTASESColaco R, Martin P, Bond J, Bindra R, Contessa J, Kluger H, Yu J, Chiang V. BM-10SYSTEMIC TREATMENT AND RADIATION NECROSIS FOLLOWING GKSRS IN THE TREATMENT OF BRAIN METASTASES. Neuro-Oncology 2014, 16: v34-v34. PMCID: PMC4217910, DOI: 10.1093/neuonc/nou240.10.
• Systemic Treatment and Radiation Necrosis Following Gamma Knife Radiosurgery in the Treatment of Brain MetastasesColaco R, Martin P, Bond J, Bindra R, Contessa J, Kluger H, Yu J, Chiang V. Systemic Treatment and Radiation Necrosis Following Gamma Knife Radiosurgery in the Treatment of Brain Metastases. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s310. DOI: 10.1016/j.ijrobp.2014.05.1035.
• Dose Selection Algorithm for Gamma Knife Treatment of Cerebral Metastases: Preliminary ResultsColaco R, Yu J, Bond J, Bindra R, Contessa J, Knisely J, Chiang V. Dose Selection Algorithm for Gamma Knife Treatment of Cerebral Metastases: Preliminary Results. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s310-s311. DOI: 10.1016/j.ijrobp.2014.05.1036.
• Laser interstitial thermal therapy for treatment of post-radiosurgery tumor recurrence and radiation necrosisPatel T, Chiang V. Laser interstitial thermal therapy for treatment of post-radiosurgery tumor recurrence and radiation necrosis. Photonics And Lasers In Medicine 2014, 3: 95-105. DOI: 10.1515/plm-2013-0057.
• Mass EffectChiang V, Awad I. Mass Effect. 2014, 1007-1008. DOI: 10.1016/b978-0-12-385157-4.00765-x.
• Prognostic Factors in Patients With Brain Metastases at Initial Non-Small Cell Lung Cancer DiagnosisRutter C, Mancini B, Yu J, Chiang V, Bindra R. Prognostic Factors in Patients With Brain Metastases at Initial Non-Small Cell Lung Cancer Diagnosis. International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s273. DOI: 10.1016/j.ijrobp.2013.06.711.
• Influence of BRAF and NRAS Mutations on Distant Intracranial Recurrence and Survival in Metastatic Melanoma Following RadiosurgeryRutter C, Giesen E, Yu J, Bindra R, Kluger H, Chiang V. Influence of BRAF and NRAS Mutations on Distant Intracranial Recurrence and Survival in Metastatic Melanoma Following Radiosurgery. International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s275. DOI: 10.1016/j.ijrobp.2013.06.717.
• Long-term Survivors After Treatment of Intracranial Metastases With RadiosurgeryDosoretz A, Aneja S, Contessa J, Bindra R, Chiang V, Yu J. Long-term Survivors After Treatment of Intracranial Metastases With Radiosurgery. International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s276. DOI: 10.1016/j.ijrobp.2013.06.721.
• SU‐E‐T‐389: Treatment Interruptions in Stereotactic Body Radiotherapy (SBRT) and Stereotactic Radiosurgery (SRS): Influence and CompensationGuo F, Chiang V, Yu J, Chang B, Bond J, Chen Z, Nath R, Deng J. SU‐E‐T‐389: Treatment Interruptions in Stereotactic Body Radiotherapy (SBRT) and Stereotactic Radiosurgery (SRS): Influence and Compensation. Medical Physics 2013, 40: 294-294. DOI: 10.1118/1.4814823.
• Role of stereotactic radiosurgery in patients with more than four brain metastasesJairam V, Chiang V, Yu JB, Knisely J. Role of stereotactic radiosurgery in patients with more than four brain metastases. CNS Oncology 2013, 2: 181-193. PMID: 24273642, PMCID: PMC3835313, DOI: 10.2217/cns.13.4.
• The Radiosensitivity of Tyrosine Kinase Driven Non-small Cell Lung CancerJohung K, Yu J, Gettinger S, Decker R, Hess J, Chiang V, Contessa J. The Radiosensitivity of Tyrosine Kinase Driven Non-small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s115. DOI: 10.1016/j.ijrobp.2012.07.201.
• TRIC or Tumor: Regrowing Lesions Following Radiosurgery for Brain Metastases — Proposal for a Histopathologic Scale Based on Correlation With SurvivalNath S, Sheridan A, Rauch P, Contessa J, Yu J, Knisely J, Minja F, Chiang V, Vortmeyer A. TRIC or Tumor: Regrowing Lesions Following Radiosurgery for Brain Metastases — Proposal for a Histopathologic Scale Based on Correlation With Survival. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s297. DOI: 10.1016/j.ijrobp.2012.07.776.
• Reply to M.C. Chamberlain et alSperduto P, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed P, Chao S, Weil R, Suh J, Bhatt A, Jensen A, Brown P, Shih H, Kirkpatrick J, Gaspar L, Fiveash J, Chiang V, Knisely J, Sperduto C, Lin N, Mehta M. Reply to M.C. Chamberlain et al. Journal Of Clinical Oncology 2012, 30: 3316-3317. DOI: 10.1200/jco.2012.43.0256.
• Outcomes Following Gamma Knife for MetastasesPark H, Yu J, Knisely J, Chiang V. Outcomes Following Gamma Knife for Metastases. 2011 DOI: 10.5772/29841.
• Reply to Drs. Mulvenna and HoltSperduto P, Chao S, Suh J, Sneed P, Luo X, Roberge D, Bhatt A, Mehta M, Jensen A, Brown P, Shih H, Kirkpatrick J, Gaspar L, Fiveash J, Chiang V, Knisely J, Sperduto C. Reply to Drs. Mulvenna and Holt. International Journal Of Radiation Oncology • Biology • Physics 2011, 81: 1194-1195. DOI: 10.1016/j.ijrobp.2010.09.047.
• Outcomes of Melanoma Brain Metastasis Management with Gamma Knife Radiosurgery +/- IpilimumabKnisely J, Chiang V, Kluger H, Flanigan J, Sznol M, Yu J. Outcomes of Melanoma Brain Metastasis Management with Gamma Knife Radiosurgery +/- Ipilimumab. International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s302-s303. DOI: 10.1016/j.ijrobp.2011.06.1787.
• Intracranial Hemorrhage in Patients with Metastatic Melanoma Treated by Gamma Knife RadiosurgeryKlein T, Barbiero F, Bond J, Knisely J, Chiang V, Yu J. Intracranial Hemorrhage in Patients with Metastatic Melanoma Treated by Gamma Knife Radiosurgery. International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s307. DOI: 10.1016/j.ijrobp.2011.06.1795.
• Postoperative Management in the Neurosurgical Critical Care UnitRedmond A, Chiang V. Postoperative Management in the Neurosurgical Critical Care Unit. 2009, 294-307. DOI: 10.1017/cbo9780511635434.024.
• Monte Carlo Investigation of Stereotactic Radiosurgery of Spinal MetastasesDeng J, Chen Z, Knisely J, Decker R, Chiang V, Nath R. Monte Carlo Investigation of Stereotactic Radiosurgery of Spinal Metastases. 2009, 25/1: 13-16. DOI: 10.1007/978-3-642-03474-9_4.
• Detection of Occult Brain Metastasis with High Resolution MRI using Double vs. Single Dose GadoliniumChamberlain D, Yu J, Roberts K, Higgins S, Mani S, Ozturk A, Chiang V, Knisely J. Detection of Occult Brain Metastasis with High Resolution MRI using Double vs. Single Dose Gadolinium. International Journal Of Radiation Oncology • Biology • Physics 2008, 72: s230-s231. DOI: 10.1016/j.ijrobp.2008.06.702.
• Survey of Radiosurgery Practitioner Attitudes on the use of Stereotactic Radiosurgery Alone for Oligometastatic Brain MetastasesKnisely J, Gross C, Castrucci W, Chiang V. Survey of Radiosurgery Practitioner Attitudes on the use of Stereotactic Radiosurgery Alone for Oligometastatic Brain Metastases. International Journal Of Radiation Oncology • Biology • Physics 2008, 72: s241-s242. DOI: 10.1016/j.ijrobp.2008.06.625.
• A Multi-institutional Validation Study of a New Prognostic Index (Graded Prognostic Assessment, GPA) for Patients with Brain MetastasesSperduto P, Sneed P, Bhatt A, Schwer A, Fiveash J, Chiang V, Knisely J, Zhu Y, Gaspar L, Mehta M. A Multi-institutional Validation Study of a New Prognostic Index (Graded Prognostic Assessment, GPA) for Patients with Brain Metastases. International Journal Of Radiation Oncology • Biology • Physics 2008, 72: s51. DOI: 10.1016/j.ijrobp.2008.06.881.
• 2069 Stereotactic Radiosurgery for Central Nervous System Parenchymal Metastases: Prognostic Factors for SurvivalDiLuna M, Chiang V, King J, Bi W, de Lotbinière A, Knisely J. 2069 Stereotactic Radiosurgery for Central Nervous System Parenchymal Metastases: Prognostic Factors for Survival. International Journal Of Radiation Oncology • Biology • Physics 2006, 66: s248. DOI: 10.1016/j.ijrobp.2006.07.472.
• Multivariate analysis identifies factors that affect survival after stereotactic radiosurgery for brain metastasesDiluna M, King J, Knisely J, Bond J, De Lotbiniere A, Chiang V. Multivariate analysis identifies factors that affect survival after stereotactic radiosurgery for brain metastases. Journal Of Clinical Oncology 2006, 24: 11500-11500. DOI: 10.1200/jco.2006.24.18_suppl.11500.
• Mass EffectChiang V, Awad I. Mass Effect. 2003, 41-43. DOI: 10.1016/b0-12-226870-9/00658-4.
• Ventriculopleural shunt obstruction and positive-pressure ventilation. Case report.Chiang V, Torbey M, Rigamonti D, Williams M. Ventriculopleural shunt obstruction and positive-pressure ventilation. Case report. Journal Of Neurosurgery 2001, 95: 116-8. PMID: 11453379, DOI: 10.3171/jns.2001.95.1.0116.
• cDNA cloning, chromosomal localization, and expression analysis of human BEHAB/brevican, a brain specific proteoglycan regulated during cortical development and in gliomaGary S, Zerillo C, Chiang V, Gaw J, Gray G, Hockfield S. cDNA cloning, chromosomal localization, and expression analysis of human BEHAB/brevican, a brain specific proteoglycan regulated during cortical development and in glioma. Gene 2000, 256: 139-147. PMID: 11054543, DOI: 10.1016/s0378-1119(00)00362-0.
• Toward more rational prediction of outcome in patients with high-grade subarachnoid hemorrhage.Chiang V, Claus E, Awad I. Toward more rational prediction of outcome in patients with high-grade subarachnoid hemorrhage. Neurosurgery 2000, 46: 28-35; discussion 35-6. PMID: 10626932, DOI: 10.1097/00006123-200001000-00006.
• Toward More Rational Prediction of Outcome in Patients with High-grade Subarachnoid HemorrhageChiang V, Claus E, Awad I. Toward More Rational Prediction of Outcome in Patients with High-grade Subarachnoid Hemorrhage. Neurosurgery 2000, 46: 28-36. DOI: 10.1093/neurosurgery/46.1.28.
• Neonatal galenic arteriovenous malformation.Chiang V, Awad I, Berenstein A, Scott M, Spetzler R, Alexander M. Neonatal galenic arteriovenous malformation. Neurosurgery 1999, 44: 847-54. PMID: 10201310, DOI: 10.1097/00006123-199904000-00087.
• Toward More Rational Outcome Prediction in Highgrade Patients with Subarachnoid HemorrhageChiang V, Claus E, Chaloupka J, Awad I. Toward More Rational Outcome Prediction in Highgrade Patients with Subarachnoid Hemorrhage. Neurosurgery 1998, 43: 717-718. DOI: 10.1097/00006123-199809000-00371.